These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20825494)

  • 1. Purvalanol A, a CDK inhibitor, effectively suppresses Src-mediated transformation by inhibiting both CDKs and c-Src.
    Hikita T; Oneyama C; Okada M
    Genes Cells; 2010 Oct; 15(10):1051-62. PubMed ID: 20825494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pro-apoptotic protein Prostate Apoptosis Response Protein-4 (Par-4) can be activated in colon cancer cells by treatment with Src inhibitor and 5-FU.
    Kline CL; Irby RB
    Apoptosis; 2011 Dec; 16(12):1285-94. PubMed ID: 21910008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purvalanol A enhances cell killing by inhibiting up-regulation of CDC2 kinase activity in tumor cells irradiated with high doses of X rays.
    Iizuka D; Inanami O; Kashiwakura I; Kuwabara M
    Radiat Res; 2007 May; 167(5):563-71. PubMed ID: 17474786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of autophagy by 3-MA potentiates purvalanol-induced apoptosis in Bax deficient HCT 116 colon cancer cells.
    Coker-Gurkan A; Arisan ED; Obakan P; Guvenir E; Unsal NP
    Exp Cell Res; 2014 Oct; 328(1):87-98. PubMed ID: 25088259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Csk-binding protein (Cbp) negatively regulates epidermal growth factor-induced cell transformation by controlling Src activation.
    Jiang LQ; Feng X; Zhou W; Knyazev PG; Ullrich A; Chen Z
    Oncogene; 2006 Sep; 25(40):5495-506. PubMed ID: 16636672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transmembrane adaptor Cbp/PAG1 controls the malignant potential of human non-small cell lung cancers that have c-src upregulation.
    Kanou T; Oneyama C; Kawahara K; Okimura A; Ohta M; Ikeda N; Shintani Y; Okumura M; Okada M
    Mol Cancer Res; 2011 Jan; 9(1):103-14. PubMed ID: 21156787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells.
    Yenugonda VM; Deb TB; Grindrod SC; Dakshanamurthy S; Yang Y; Paige M; Brown ML
    Bioorg Med Chem; 2011 Apr; 19(8):2714-25. PubMed ID: 21440449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of the tumor suppressor gene C-terminal Src kinase: an early event during premalignant colonic epithelial hyperproliferation.
    Kunte DP; Wali RK; Koetsier JL; Hart J; Kostjukova MN; Kilimnik AY; Pyatkin IG; Strelnikova SR; Roy HK
    FEBS Lett; 2005 Jul; 579(17):3497-502. PubMed ID: 15961079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models.
    Golas JM; Lucas J; Etienne C; Golas J; Discafani C; Sridharan L; Boghaert E; Arndt K; Ye F; Boschelli DH; Li F; Titsch C; Huselton C; Chaudhary I; Boschelli F
    Cancer Res; 2005 Jun; 65(12):5358-64. PubMed ID: 15958584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol.
    Knockaert M; Lenormand P; Gray N; Schultz P; Pouysségur J; Meijer L
    Oncogene; 2002 Sep; 21(42):6413-24. PubMed ID: 12226745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin-induced epithelial-mesenchymal transition and ER stress are regulated through a common ROS-c-Src kinase-mTOR pathway: effect of imatinib mesylate.
    Lee JY; Chang JW; Yang WS; Kim SB; Park SK; Park JS; Lee SK
    Am J Physiol Renal Physiol; 2011 May; 300(5):F1214-22. PubMed ID: 21367918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose 6-phosphate dehydrogenase is regulated through c-Src-mediated tyrosine phosphorylation in endothelial cells.
    Pan S; World CJ; Kovacs CJ; Berk BC
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):895-901. PubMed ID: 19359662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of c-Src/HER1/STAT5b and HER1/ERK1/2 signaling pathways and cell migration by hexachlorobenzene in MDA-MB-231 human breast cancer cell line.
    Pontillo CA; García MA; Peña D; Cocca C; Chiappini F; Alvarez L; Kleiman de Pisarev D; Randi AS
    Toxicol Sci; 2011 Apr; 120(2):284-96. PubMed ID: 21205633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raf-1 kinase activation is uncoupled from downstream MEK/ERK pathway in cells treated with Src tyrosine kinase inhibitor PP2.
    Lee M
    Biochem Biophys Res Commun; 2006 Nov; 350(2):450-6. PubMed ID: 17010316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of proteinase-activated receptor 1 promotes human colon cancer cell proliferation through epidermal growth factor receptor transactivation.
    Darmoul D; Gratio V; Devaud H; Peiretti F; Laburthe M
    Mol Cancer Res; 2004 Sep; 2(9):514-22. PubMed ID: 15383630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional dissection of transformation by c-Src and v-Src.
    Oneyama C; Hikita T; Nada S; Okada M
    Genes Cells; 2008 Jan; 13(1):1-12. PubMed ID: 18173743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of MAP kinase by muscarinic cholinergic receptors induces cell proliferation and protein synthesis in human breast cancer cells.
    Jiménez E; Montiel M
    J Cell Physiol; 2005 Aug; 204(2):678-86. PubMed ID: 15744749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.
    Tan M; Li P; Sun M; Yin G; Yu D
    Oncogene; 2006 Jun; 25(23):3286-95. PubMed ID: 16407820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Src kinases by a selective tyrosine kinase inhibitor causes mitotic arrest.
    Moasser MM; Srethapakdi M; Sachar KS; Kraker AJ; Rosen N
    Cancer Res; 1999 Dec; 59(24):6145-52. PubMed ID: 10626805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lipid raft-anchored adaptor protein Cbp controls the oncogenic potential of c-Src.
    Oneyama C; Hikita T; Enya K; Dobenecker MW; Saito K; Nada S; Tarakhovsky A; Okada M
    Mol Cell; 2008 May; 30(4):426-36. PubMed ID: 18498747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.